When viewing this topic in a different language, you may notice some differences in the way the content is structured, but it still reflects the latest evidence-based guidance.

Autoimmune hepatitis

Last reviewed: 27 Sep 2025
Last updated: 22 Mar 2024

Summary

Definition

History and exam

Key diagnostic factors

  • fatigue/malaise
  • anorexia
  • abdominal discomfort
  • hepatomegaly
  • jaundice
  • encephalopathy
Full details

Other diagnostic factors

  • pruritus
  • arthralgia
  • nausea
  • amenorrhea
  • spider angiomata
  • fever
  • maculopapular skin rash
  • gastrointestinal bleeding
  • splenomegaly
  • ascites
Full details

Risk factors

  • female sex
  • genetic predisposition
  • immune dysregulation
  • measles virus
  • cytomegalovirus
  • Epstein-Barr virus
  • hepatitis viruses A, C, and D
  • certain drugs
Full details

Diagnostic tests

1st tests to order

  • aspartate transaminase
  • alanine transaminase
  • bilirubin
  • gamma glutamyl transferase (gamma-GT)
  • alkaline phosphatase
  • serum globulin
  • serum albumin
  • prothrombin time
Full details

Tests to consider

  • antinuclear antibodies (ANAs)
  • smooth muscle antibodies (SMAs)
  • anti-soluble liver antigens or liver/pancreas (anti-SLA/LP)
  • perinuclear antineutrophil cytoplasmic antibodies (pANCA)
  • antibodies against single-stranded DNA (anti-ssDNA)
  • antibodies against double-stranded DNA (anti-dsDNA)
  • antibodies to liver/kidney microsome type 1 antigen (anti-LKM-1)
  • antibodies to liver/kidney microsome type 3 antigen (anti-LKM-3)
  • antibodies to liver cytosol 1 antigen (anti-LC1)
  • antimitochondrial antibodies (AMAs)
  • antibodies against asialoglycoprotein receptor (anti-ASGP-R)
  • IgM antibodies to hepatitis A virus (IgM anti-HAV)
  • hepatitis B surface antigen (HBsAg)
  • antibodies to hepatitis B core antigen (anti-HBc)
  • hepatitis C antibodies and viral RNA
  • ceruloplasmin
  • alpha-1 antitrypsin
  • serum iron and total iron binding capacity
  • thiopurine methyltransferase (TPMT) activity
  • abdominal ultrasound
  • liver biopsy
Full details

Emerging tests

  • Transient elastography (TE)

Treatment algorithm

INITIAL

acute severe disease

ACUTE

active disease

inactive disease or minimally active disease with comorbidities

AIH-primary biliary cirrhosis overlap syndrome

ONGOING

inadequate response to initial therapy or single relapse: without hepatic decompensation

multiple previous relapses: without hepatic decompensation

decompensated liver disease

Contributors

Authors

George Y. Wu, MD, PhD
George Y. Wu

Professor Emeritus

Division of Gastroenterology - Hepatology

University of Connecticut School of Medicine

Farmington

CT

Disclosures

GYW presents lectures on autoimmune hepatitis nationally and internationally. He has acted as an expert witness for legal firms, is comprehensive editor in chief of the Journal of Clinical and Translational Hepatology, associate editor in chief of Medjaden, associate editor at the Journal of Digestive Diseases, and a book series editor for Springer-Nature, and a consultant in mitochondrial diseases at Mitrix Bio, Inc.

Roopjeet K. Bath, MBBS
Roopjeet K. Bath

Assistant Professor of Medicine

University of Connecticut School of Medicine

Farmington

CT

Declarações

RKB declares that she has no competing interests.

Agradecimentos

Dr George Y. Wu and Dr Roopjeet K. Bath would like to gratefully acknowledge Dr Micheal Tadros, Dr Lucija Virovic Jukic, Dr Marcy L. Coash, and Dr Deepika Devuni, previous contributors to this topic. Dr Wu would also like to acknowledge the assistance of Dr Nathan Selky in the 2011 update.

Declarações

MT, LVJ, MLC, and DD declare that they have no competing interests.

Revisores

Kittichai Promrat, MD

Assistant Professor

Division of Gastroenterology

Department of Medicine

Brown University

RI

Declarações

KP declares that he has no competing interests.

Créditos aos pareceristas

Os tópicos do BMJ Best Practice são constantemente atualizados, seguindo os desenvolvimentos das evidências e das diretrizes. Os pareceristas aqui listados revisaram o conteúdo pelo menos uma vez durante a história do tópico.

Declarações

As afiliações e declarações dos pareceristas referem--se ao momento da revisão.

Referências

Nossas equipes internas de editoria e de evidências trabalham em conjunto com colaboradores internacionais especializados e pares revisores para garantir que forneçamos acesso às informações o mais clinicamente relevantes possível.

Principais artigos

Mack CL, Adams D, Assis DN, et al. Diagnosis and management of autoimmune hepatitis in adults and children: 2019 practice guidance and guidelines from the American Association for the Study of Liver Diseases. Hepatology. 2020 Aug;72(2):671-722.Texto completo  Resumo

European Association for the Study of the Liver. EASL clinical practice guidelines: autoimmune hepatitis. J Hepatol. 2015 Oct;63(4):971-1004. Resumo

Gleeson D, Heneghan MA; British Society of Gastroenterology. British Society of Gastroenterology (BSG) guidelines for management of autoimmune hepatitis. Gut. 2011 Dec;60(12):1611-29.Texto completo  Resumo

Strassburg CP, Manns MP. Treatment of autoimmune hepatitis. Semin Liver Dis. 2009 Aug;29(3):273-85. Resumo

Selvarajah V, Montano-Loza AJ, Czaja AJ. Systematic review: managing suboptimal treatment responses in autoimmune hepatitis with conventional and nonstandard drugs. Aliment Pharmacol Ther. 2012 Oct;36(8):691-707.Texto completo  Resumo

Artigos de referência

Uma lista completa das fontes referenciadas neste tópico está disponível para os usuários com acesso total ao BMJ Best Practice.
  • Diagnósticos diferenciais

    • Primary biliary cirrhosis
    • Primary sclerosing cholangitis
    • Chronic hepatitis B
    Mais Diagnósticos diferenciais
  • Diretrizes

    • ACR appropriateness criteria: abnormal liver function tests
    • Clinical practice guidelines: non-invasive tests for evaluation of liver disease severity and prognosis
    Mais Diretrizes
  • padlock-lockedConectar-se ou assinar para acessar todo o BMJ Best Practice

O uso deste conteúdo está sujeito ao nosso aviso legal